Free Trial

Ligand Pharmaceuticals (LGND) Short Interest Ratio & Short Volume

Ligand Pharmaceuticals logo
$159.76 +0.97 (+0.61%)
Closing price 08/26/2025 04:00 PM Eastern
Extended Trading
$159.79 +0.03 (+0.02%)
As of 06:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ligand Pharmaceuticals Short Interest Data

Ligand Pharmaceuticals (LGND) has a short interest of 915,900 shares, representing 5.10% of the float (the number of shares available for trading by the public). This marks a -25.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.4, indicating that it would take 5.4 days of the average trading volume of 316,166 shares to cover all short positions.

Current Short Interest
915,900 shares
Previous Short Interest
1,230,000 shares
Change Vs. Previous Month
-25.54%
Dollar Volume Sold Short
$120.51 million
Short Interest Ratio
5.4 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
19,597,000 shares
Short Percent of Float
5.10%
Today's Trading Volume
102,134 shares
Average Trading Volume
316,166 shares
Today's Volume Vs. Average
32%
Short Selling Ligand Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

LGND Short Interest Over Time

LGND Days to Cover Over Time

LGND Percentage of Float Shorted Over Time

Ligand Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2025915,900 shares $120.51 million -25.5%5.1%5.4 $131.58
7/15/20251,230,000 shares $152.89 million +3.4%N/A8.7 $124.30
6/30/20251,190,000 shares $135.28 million +3.5%6.6%9.7 $113.68
6/15/20251,150,000 shares $129.38 million -6.5%6.4%9.7 $112.50
5/31/20251,230,000 shares $126.90 million +12.8%6.9%10.2 $103.17
5/15/20251,090,000 shares $112.78 million -10.7%6.1%8.9 $103.47
4/30/20251,220,000 shares $134.03 million +7.0%N/A10.2 $109.86
4/15/20251,140,000 shares $121.75 million +12.9%6.4%10.1 $106.80
3/31/20251,010,000 shares $106.19 million +5.8%5.7%9 $105.14
3/15/2025955,100 shares $101.42 million +22.4%5.4%8.3 $106.19
2/28/2025780,100 shares $95.35 million -7.7%4.4%7.1 $122.23
2/15/2025845,000 shares $101.40 million -11.2%4.8%8 $120.00
1/31/2025951,500 shares $110.90 million +4.4%N/A8.2 $116.55
1/15/2025911,400 shares $100.51 million +1.3%N/A7.4 $110.28
12/31/2024900,100 shares $96.45 million +10.7%N/A7.5 $107.15
12/15/2024812,800 shares $95.02 million +3.5%N/A6.9 $116.91
11/30/2024785,700 shares $95.44 million -5.5%N/A7.1 $121.47
11/15/2024831,500 shares $92.89 million -9.5%N/A7.5 $111.71
10/31/2024918,600 shares $97.10 million -8.1%N/A8.5 $105.70
10/15/20241,000,000 shares $104.39 million +0.4%N/A9.5 $104.39
9/30/2024996,100 shares $99.70 million +1.9%N/A8.7 $100.09
9/15/2024977,400 shares $102.40 million -1.8%N/A7.9 $104.77
8/31/2024995,000 shares $105.27 million -6.1%N/A8.1 $105.80
8/15/20241,060,000 shares $109.32 million +10.3%N/A8.3 $103.13
7/31/2024960,700 shares $104.71 million -12.7%N/A6.9 $108.99
7/15/20241,100,000 shares $106.34 million +17.7%N/A7.9 $96.67
6/30/2024934,400 shares $78.73 million -0.2%N/A6.5 $84.26
6/15/2024936,600 shares $74.98 million +32.3%N/A6.6 $80.06
5/31/2024707,700 shares $60.19 million -17.6%N/A4.3 $85.05
5/15/2024858,700 shares $73.65 million +7.9%N/A4.6 $85.77
4/30/2024795,600 shares $55.60 million -3.8%N/A4.3 $69.89
4/15/2024826,600 shares $65.94 million +23.0%5.0%4.9 $79.77
3/31/2024672,100 shares $49.13 million -23.3%4.1%4.1 $73.10
3/15/2024876,300 shares $62.30 million +14.9%5.3%5.8 $71.09
2/29/2024762,600 shares $60.51 million -15.0%4.6%5.3 $79.35
2/15/2024896,600 shares $66.93 million -3.6%5.5%7.3 $74.65
1/31/2024929,800 shares $67.97 million +1.0%5.7%8.1 $73.10
1/15/2024920,700 shares $66.84 million +2.2%6.9%8.2 $72.60
12/31/2023900,800 shares $64.34 million +0.8%5.5%8.2 $71.42
12/15/2023893,600 shares $60.18 million -1.7%5.5%8.1 $67.35
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
11/30/2023909,100 shares $53.01 million -2.3%5.5%8.8 $58.31
11/15/2023930,200 shares $52.54 million +6.1%5.7%9.2 $56.48
10/31/2023876,400 shares $45.83 million +3.8%5.4%8.8 $52.29
10/15/2023844,700 shares $46.45 million +2.5%5.2%8.8 $54.99
9/30/2023824,100 shares $49.38 million -0.1%5.1%8.4 $59.92
9/15/2023825,000 shares $51.13 million -6.2%5.1%8.8 $61.98
8/31/2023879,200 shares $57.82 million +4.6%5.4%9.1 $65.77
8/15/2023840,500 shares $56.81 million +4.3%5.2%8.6 $67.59
7/31/2023805,800 shares $53.93 million -3.4%5.0%8.2 $66.93
7/15/2023834,300 shares $56.61 million -1.4%5.1%8.4 $67.85
6/30/2023846,200 shares $61.01 million +4.0%5.2%8.6 $72.10
6/15/2023814,000 shares $64.30 million -1.6%5.0%7.8 $78.99
5/31/2023827,100 shares $57.96 million +1.3%5.1%7.9 $70.08
5/15/2023816,400 shares $63.34 million +0.7%5.0%7.2 $77.59
4/30/2023811,100 shares $61.93 million +5.1%5.1%7 $76.35
4/15/2023771,800 shares $57.38 million -1.0%4.8%6.6 $74.34
3/31/2023779,200 shares $57.32 million -13.5%4.9%6.5 $73.56
3/15/2023900,500 shares $64.48 million +7.5%5.6%7.1 $71.61
2/28/2023838,100 shares $60.46 million +2.5%5.2%5.1 $72.14
2/15/2023817,900 shares $59.69 million +1.5%5.1%4.8 $72.98
1/31/2023806,000 shares $56.18 million +0.1%5.1%4.6 $69.70
1/15/2023805,000 shares $57.38 million +1.5%5.1%4.1 $71.28
12/30/2022792,800 shares $52.96 million -8.4%5.0%4.1 $66.80
12/15/2022865,800 shares $53.81 million +13.0%5.5%4.4 $62.15
11/30/2022766,100 shares $55.85 million -2.3%4.8%4.6 $72.90
11/15/2022784,100 shares $61.99 million +6.6%4.9%5 $79.06
10/31/2022735,400 shares $64.46 million -0.3%4.6%5 $87.65
10/15/2022737,800 shares $66.03 million -6.7%4.6%6 $89.49
9/30/2022790,600 shares $68.08 million -5.1%5.0%6.6 $86.11
9/15/2022833,000 shares $75.08 million +3.1%5.2%7 $90.13
8/31/2022808,200 shares $74.67 million -3.7%5.1%6.6 $92.39
8/15/2022839,000 shares $90.03 million -3.2%5.3%6.8 $107.31
7/31/2022866,700 shares $79.76 million -0.8%5.4%6.5 $92.03
7/15/2022873,600 shares $82.58 million -3.6%5.4%6 $94.53
6/30/2022905,800 shares $80.82 million -0.2%5.6%6 $89.22
6/15/2022907,900 shares $71.80 million -0.6%N/A5.7 $79.08
5/31/2022913,400 shares $81.21 million -10.5%5.7%6.2 $88.91
5/15/20221,020,000 shares $87.68 million -8.9%6.4%6.2 $85.96
4/30/20221,120,000 shares $104.00 million No Change7.0%6.8 $92.86
4/15/20221,120,000 shares $117.89 million -8.9%7.0%6.8 $105.26
3/31/20221,230,000 shares $138.36 million +2.5%7.7%7.2 $112.49
3/15/20221,200,000 shares $125.44 million -2.4%7.5%7.5 $104.53
2/28/20221,230,000 shares $124.50 million No Change7.7%7.7 $101.22
2/15/20221,230,000 shares $152.13 million -10.2%7.8%8.1 $123.68
1/31/20221,370,000 shares $170.74 million -11.0%8.6%9.7 $124.63
1/15/20221,540,000 shares $192.36 million -4.4%9.7%11.3 $124.91
12/31/20211,610,000 shares $248.68 million -4.2%10.1%13.4 $154.46
12/15/20211,680,000 shares $247.80 million +5.0%10.6%13.9 $147.50
11/30/20211,600,000 shares $259.07 million +0.6%10.1%13.5 $161.92
11/15/20211,590,000 shares $260.93 million -4.2%10.0%8 $164.11
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
10/29/20211,660,000 shares $242.26 million No Change10.5%8 $145.94
10/15/20211,660,000 shares $216.23 million -4.1%10.5%7.9 $130.26
9/30/20211,730,000 shares $241.02 million -2.8%10.9%8 $139.32
9/15/20211,780,000 shares $241.83 million +10.6%11.2%7.8 $135.86
8/31/20211,610,000 shares $213.00 million -0.6%10.2%7 $132.30
8/13/20211,620,000 shares $173.05 million -1.8%10.2%10.1 $106.82
7/30/20211,650,000 shares $187.29 million -6.3%10.4%11 $113.51
7/15/20211,760,000 shares $203.84 million +0.6%11.1%11.7 $115.82
6/30/20211,750,000 shares $229.58 million +1.7%11.0%11.7 $131.19
6/15/20211,720,000 shares $212.97 million +8.2%10.8%12 $123.82
5/28/20211,590,000 shares $187.14 million -0.6%10.0%9.8 $117.70
5/14/20211,600,000 shares $198.21 million -0.6%10.1%8.5 $123.88
4/30/20211,610,000 shares $234.69 million +2.6%10.1%6.1 $145.77
4/15/20211,570,000 shares $237.12 million +4.7%9.9%2.9 $151.03
3/31/20211,500,000 shares $223.67 million -19.4%9.5%2.6 $149.11
3/15/20211,860,000 shares $306.49 million -15.8%11.8%3 $164.78
2/26/20212,210,000 shares $331.96 million -19.3%14.0%3.6 $150.21
2/12/20212,740,000 shares $493.31 million -54.1%17.9%4.5 $180.04
1/29/20215,970,000 shares $1.14 billion -40.4%38.9%10.3 $191.59
1/15/202110,010,000 shares $1.22 billion +1.0%64.9%21.5 $122.28
12/31/20209,910,000 shares $1.02 billion -0.7%64.2%28.9 $102.63
12/15/20209,980,000 shares $1.02 billion -1.6%64.7%29.5 $101.79
11/30/202010,140,000 shares $871.23 million -4.6%65.7%30.6 $85.92
11/15/202010,630,000 shares $889.84 million -1.0%68.9%32.7 $83.71
10/30/202010,740,000 shares $892.17 million +5.1%69.6%34.8 $83.07
10/15/202010,220,000 shares $1.02 billion +3.9%66.2%34.7 $100.01
9/30/20209,840,000 shares $937.95 million +6.0%63.8%39.7 $95.32
9/15/20209,280,000 shares $890.79 million +3.0%60.1%35 $95.99
8/31/20209,010,000 shares $919.02 million +0.9%58.4%34.6 $102.00

LGND Short Interest - Frequently Asked Questions

What is Ligand Pharmaceuticals' current short interest?

Short interest is the volume of Ligand Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 915,900 shares of LGND short. 5.10% of Ligand Pharmaceuticals' shares are currently sold short. Learn More on Ligand Pharmaceuticals' current short interest.

What is a good short interest ratio for Ligand Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LGND shares currently have a short interest ratio of 5.0. Learn More on Ligand Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Ligand Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ligand Pharmaceuticals: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ligand Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.10% of Ligand Pharmaceuticals' floating shares are currently sold short.

Is Ligand Pharmaceuticals' short interest increasing or decreasing?

Ligand Pharmaceuticals saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 915,900 shares, a decline of 25.5% from the previous total of 1,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ligand Pharmaceuticals' short interest compare to its competitors?

5.10% of Ligand Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ligand Pharmaceuticals: ADMA Biologics Inc (5.96%), ANI Pharmaceuticals, Inc. (11.48%), BioMarin Pharmaceutical Inc. (2.71%), Exelixis, Inc. (6.67%), Madrigal Pharmaceuticals, Inc. (22.84%), Exact Sciences Corporation (3.68%), Halozyme Therapeutics, Inc. (8.58%), Repligen Corporation (6.84%), Ionis Pharmaceuticals, Inc. (7.45%), Alkermes plc (8.76%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Ligand Pharmaceuticals stock?

Short selling LGND is an investing strategy that aims to generate trading profit from Ligand Pharmaceuticals as its price is falling. LGND shares are trading up $0.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ligand Pharmaceuticals?

A short squeeze for Ligand Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LGND, which in turn drives the price of the stock up even further.

How often is Ligand Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LGND, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:LGND) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners